Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Louise Crivelli

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Frontiers in Oncology|February 18, 2026
From genetic risk to early detection - clinical outcomes of a person-centered screening program for women with a high genetic risk of breast cancerKe Zhou, Caroline Abadie, Louise Crivelli, et al.
The Oncologist|April 2, 2024
Factors Influencing Adherence to the Risk Management Program for Women With a Genetic Predisposition to Breast Cancer: Real-World Data from a French Multicenter ProgramKe Zhou, Martine Bellanger, Louise Crivelli, et al.
European Journal of Human Genetics : EJHG|May 18, 2017
Insertion of Alu elements at a PTEN hotspot in Cowden syndromeLouise Crivelli, Virginie Bubien, Natalie Jones, et al.
Journal of Medical Genetics|October 2, 2024
Classification of <i>PTEN</i> germline non-truncating variants: a new approach to interpretationHenri Margot, Natalie Jones, Thibaut Matis, et al.
BMC Genomics|September 30, 2024
Fine mapping of RNA isoform diversity using an innovative targeted long-read RNA sequencing protocol with novel dedicated bioinformatics pipelineCamille Aucouturier, Nicolas Soirat, Laurent Castéra, et al.
European Journal of Medical Genetics|November 21, 2025
French recommendations on multi-gene panel testing in renal cell carcinomaSophie Giraud, Pascaline Berthet, Caroline Abadie, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2025
Letrozole to prevent breast cancer in postmenopausal women with BRCA1/2 mutations (LIBER study)Pascal Pujol, Lise Roca, Alain Lortholary, et al.
Gynecologic Oncology|October 13, 2019
Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancersS Intidhar Labidi-Galy, Thibault de La Motte Rouge, Olfa Derbel, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 29, 2026
Cancer risks for ATM variant heterozygotesYue Jiao, David E Goldgar, Dorothée Le Gal, et al.
Cancers|August 7, 2021
TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel TestingFabienne Lesueur, Séverine Eon-Marchais, Sarah Bonnet-Boissinot, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Frontiers in Oncology|February 18, 2026
From genetic risk to early detection - clinical outcomes of a person-centered screening program for women with a high genetic risk of breast cancerKe Zhou, Caroline Abadie, Louise Crivelli, et al.
The Oncologist|April 2, 2024
Factors Influencing Adherence to the Risk Management Program for Women With a Genetic Predisposition to Breast Cancer: Real-World Data from a French Multicenter ProgramKe Zhou, Martine Bellanger, Louise Crivelli, et al.
European Journal of Human Genetics : EJHG|May 18, 2017
Insertion of Alu elements at a PTEN hotspot in Cowden syndromeLouise Crivelli, Virginie Bubien, Natalie Jones, et al.
Journal of Medical Genetics|October 2, 2024
Classification of <i>PTEN</i> germline non-truncating variants: a new approach to interpretationHenri Margot, Natalie Jones, Thibaut Matis, et al.
BMC Genomics|September 30, 2024
Fine mapping of RNA isoform diversity using an innovative targeted long-read RNA sequencing protocol with novel dedicated bioinformatics pipelineCamille Aucouturier, Nicolas Soirat, Laurent Castéra, et al.
European Journal of Medical Genetics|November 21, 2025
French recommendations on multi-gene panel testing in renal cell carcinomaSophie Giraud, Pascaline Berthet, Caroline Abadie, et al.
European Journal of Cancer (Oxford, England : 1990)|November 15, 2025
Letrozole to prevent breast cancer in postmenopausal women with BRCA1/2 mutations (LIBER study)Pascal Pujol, Lise Roca, Alain Lortholary, et al.
Gynecologic Oncology|October 13, 2019
Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancersS Intidhar Labidi-Galy, Thibault de La Motte Rouge, Olfa Derbel, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 29, 2026
Cancer risks for ATM variant heterozygotesYue Jiao, David E Goldgar, Dorothée Le Gal, et al.
Cancers|August 7, 2021
TUMOSPEC: A Nation-Wide Study of Hereditary Breast and Ovarian Cancer Families with a Predicted Pathogenic Variant Identified through Multigene Panel TestingFabienne Lesueur, Séverine Eon-Marchais, Sarah Bonnet-Boissinot, et al.
Pageof 2